FainsingerR, MacEachernT, HansonJ, MillerMJ, BrueraE.Symptom control during the last week of life on a palliative care unit. J Palliat Care1991; 7(1): 5–11.
VentafriddaV, RipamontiC, De ConnoF, TamburiniM, CassilethB.Symptom prevalence and control during cancer patients’ last days of life. J Palliat Care1990; 6(3): 7–11.
4.
BillingsJA. Dyspnea, cough and other respiratory symptoms. In: BillingsJA-(ed). Outpatient Management of Advanced Cancer. Philadelphia: JB Lippincott, 1985: 83.
5.
WoodcockAA, GrossER, GeddesDM. Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Brit Med J1981; 283: 343–346.
6.
StarkRD, GamblesSA, LewisJA. Methods to assess breathlessness in healthy subjects: a critical evaluation and application to analyse the acute effects of diazepam and promethazine on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. Clin Sci1981; 61: 429–439.
7.
ManGCW, HsuK, SprouleBJ. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest1986; 90: 832–836.
8.
WoodcockAA, GrossER, GellertA, ShahS, JohnsonM, GeddesDM. Effects of dihydrocodeine, alcohol and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med1981; 305: 1611–1616.
9.
BrowningI, D'AlonzoGE, TobinMJ. Effect of hydrocodone on dyspnea, respiratory drive and exercise performance in adult patients with cystic fibrosis. Am Rev Respir Dis1988; 137: A305 (abstract).
